Literature DB >> 20010965

Growth and development: congenital adrenal hyperplasia-glucocorticoids and height.

Phyllis W Speiser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20010965     DOI: 10.1038/nrendo.2009.242

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

Review 1.  Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology.

Authors: 
Journal:  J Clin Endocrinol Metab       Date:  2002-09       Impact factor: 5.958

2.  Randomised controlled trial of growth effect of hydrocortisone in congenital adrenal hyperplasia.

Authors:  I N Silva; C E Kater; C F Cunha; M B Viana
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

3.  Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia.

Authors:  Karen Lin-Su; Maria G Vogiatzi; Ian Marshall; Madeleine D Harbison; Maria C Macapagal; Brian Betensky; Susan Tansil; Maria I New
Journal:  J Clin Endocrinol Metab       Date:  2005-03-29       Impact factor: 5.958

Review 4.  Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.

Authors:  G Hargitai; J Sólyom; T Battelino; J Lebl; Z Pribilincová; R Hauspie; J Kovács; F Waldhauser; H Frisch
Journal:  Horm Res       Date:  2001

5.  Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential.

Authors:  Zehra Aycan; Gonul Ocal; Merih Berberoglu; Ergun Cetinkaya; Pelin Adiyaman; Olcay Evliyaoglu
Journal:  J Pediatr Endocrinol Metab       Date:  2006-03       Impact factor: 1.634

6.  Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia.

Authors:  D P Merke; M F Keil; J V Jones; J Fields; S Hill; G B Cutler
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

7.  Growth of patients with 21-hydroxylase deficiency: an analysis of the factors influencing adult height.

Authors:  J Jääskeläinen; R Voutilainen
Journal:  Pediatr Res       Date:  1997-01       Impact factor: 3.756

8.  Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth.

Authors:  S A Rivkees; J D Crawford
Journal:  Pediatrics       Date:  2000-10       Impact factor: 7.124

9.  Prednisolone in the treatment of adrenal insufficiency: a re-evaluation of relative potency.

Authors:  Zubin Punthakee; Laurent Legault; Constantin Polychronakos
Journal:  J Pediatr       Date:  2003-09       Impact factor: 4.406

10.  Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation.

Authors:  Walter Bonfig; Susanne Bechtold Dalla Pozza; Heinrich Schmidt; Philipp Pagel; Dietrich Knorr; Hans Peter Schwarz
Journal:  J Clin Endocrinol Metab       Date:  2009-07-21       Impact factor: 5.958

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.